HARRISBURG, PA (WHTM) – January 5, 2021
“Through the Ben Franklin Technology Partners (BFTP), DCED supports early-stage technology companies and established manufacturers as they help us use innovation to recover from the economic effects of the coronavirus,” said Deputy Secretary D’Ettorre. “LifeAire is an outstanding example of a young company that has responded swiftly and effectively to this pandemic.”
In April 2020, the DCED granted funding to support technology-based companies impacted by COVID-19, including the disbursement of $100,000 to LifeAire recipient to continue the development of its products.
LifeAire’s air purification systems were originally designed for highly sensitive In Vitro Fertilization facilities and are used to kill or inactivate infectious airborne pathogens, which also killed the airborne coronavirus and influenza on a single pass through the system.
Units were placed in hospitals, senior living facilities, dental practices, commercial office spaces, transportation, and educational facilities.
For full story click here
About LifeAire Systems
LifeAire Systems is an innovative healthcare technology company that
provides advanced air filtration systems exclusively for the healthcare and life sciences industries. The patented, multi-stage purification system remediates up to 99.99% of biological and chemical contaminants in both source and return air. LifeAire makes the environment safer for patients and medical staff, resulting in significant improvement in clinical outcomes. For more information, please visit the LifeAire
Systems’ website at lifeaire.com.